CTGCT
  • en
    • si
  • About us
    • About CTGCT
    • Partners
    • CTGCT Days 2025
    • Funding of the CTGCT
  • Job Openings
  • Products and Services
  • Learning Box
    • Learning Box
    • CTGCT Science Talks
    • Publications
  • POSTS
    • Events
    • Articles
    • News
    • All posts
  • Get in touch

Research

  • Articles
  • Pacients
  • Research
  • CTGCT
11 February 2025

Women at CTGCT: Voices from the Lab

Today we we celebrate the International Day of Women and Girls in Science, we take a moment to spotlight the women working at the Centre for the Technologies of Gene and Cell Therapy (CTGCT)

Women In Science Cover, image generated using AI, Dall-e
  • Articles
  • Pacients
  • Researchers
  • Gen Therapy
  • Laboratory
  • Pre Clinical
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
28 January 2025

The research on combining cytokines with pyroptosis is gaining widespread media coverage

Research on combining cytokines and pyroptosis for cancer therapy by Slovenian scientists has gained significant media recognition, including TV features, articles, and the honor of being named "Names of the Week".

Odmevi Sara N Iva
  • Media Releases
  • Clinicians
  • Pacients
  • Researchers
  • ATMPs
  • Economics
  • Research
  • CTGCT
  • NIC
  • Gregor Cuzak
22 January 2025

Slovenia Joins ERDERA to Advance Rare Disease Research and Collaboration

CTGCT welcomes Slovenia's entry into the European Research Partnership for Rare Diseases ERDERA

Erdera
  • Media Releases
  • Pacients
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
10 January 2025

Head of CTGCT research selected as breakthrough discovery by the national TV in Slovenia

Check this video were he Head of the #CTGCT prof. dr. Mojca Benčina appeared in the news of the Slovenian national TV since her researched was selected as one of the breakthrough discoveries by ...

Mojca Rtve1 Discover Of The Year 2024
  • Articles
  • Clinicians
  • Pacients
  • Cell therapy
  • Gen Therapy
  • Laboratory
  • Pre Clinical
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
7 January 2025

Combining cytokines and pyroptosis, a promising weapon against cancer

A recent study published in Nature Communications has unveiled a groundbreaking approach that combines the power of cytokines with a type of cell death called pyroptosis to boost the immune system's ability to fight ...

Cytokine Pyroptosis
  • Latest
  • Media Releases
  • Clinicians
  • Pacients
  • Researchers
  • Research
  • CTGCT
  • Rodrigo Ortiz
  • Rodrigo Ortiz
11 December 2024

CTGCT Newsletter, 1st year in review

Welcome to the first CTGCT Newsletter featuring a selection of the articles we're most proud of in the last year.

  • Articles
  • Media Releases
  • Researchers
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Research
  • Charite Berlin
  • CTGCT
  • NIC
  • TUD
  • UCL
  • UMCUtrecht
  • Rodrigo Ortiz
6 December 2024

CTGCT’s Innovation Report on Gene and Cell Therapy

We are pleased to share that our latest paper has been accepted for publication in the Computational and Structural Biotechnology Journal (CSBJ)

Innovation Report Abstract
  • Articles
  • Pacients
  • Gen Therapy
  • Drug Discovery
  • Laboratory
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
22 November 2024

MyD88 balances cell homeostasis by regulating immune response, mitochondrial function and cell death

A recent study by researchers in the CTGCT investigates the role of the MyD88 protein, a key player in innate immune signaling pathways.

Myd88 Blogpost Cover
  • Events
  • Clinicians
  • Pacients
  • Researchers
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Business Model
  • Drug Discovery
  • Economics
  • Investment
  • Marketaccess
  • Regulation
  • Research
  • CTGCT
  • Gregor Cuzak
12 September 2024 Event Date: 6 September 2024 • 09:00 do: 6 September 2024 •

European Commission Hosts Sixth Regional HTA Event in Budapest

The European Commission recently held its sixth regional event in Budapest, focusing on the upcoming Health Technology Assessment (HTA) regulation. Set to launch in January 2025, this new framework aims to streamline the evaluation ...

Hta 20230511 Banner 0
  • Articles
  • Pacients
  • Researchers
  • Cell therapy
  • Gen Therapy
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
30 August 2024

Exciting news in Sonogenetics: A New Frontier for Deep Tissue Treatment

Researchers have made a discovery that could change how we treat some diseases deep within the human body. This technique, known as sonogenetics, combines the power of ultrasound with genetically engineered cells to deliver ...

Graphical Abstract Sonogenetics
  • Events
  • Clinicians
  • Researchers
  • Gen Therapy
  • Drug Discovery
  • Research
  • CTGCT
  • NIC
  • Gregor Cuzak
17 July 2024

CTGCT about on/off switching of CAR-Ts at the EBMT 2024

Assoc. Prof Dr Mojca Benčina, head of the newly founded Slovenian Centre for the Technologies of Gene and Cell Therapy (CTGCT), gave a speech at the recent 50th Annual Meeting of the European Society ...

Featured Up Regulation
  • Clinicians
  • Researchers
  • Cell therapy
  • Gen Therapy
  • GMP
  • Business Model
  • Clinic study
  • Drug Discovery
  • Economics
  • Investment
  • Logistics
  • Pre Clinical
  • Research
  • CTGCT
  • NIC
  • UCL
  • Gregor Cuzak
17 July 2024

UCL ATMP Pipeline

Our partner University College London (UCL) have produced a great short brochure (link) showing the strength and depth  of their pipeline of ATMPs. They use a managed portfolio approach in which they support ~100 ...

Pipeline By Number Of Projects

Posts pagination

1 2 3 4

Logo Foot

Center for the Technologies of Gene and Cell Therapies (CTGCT) is an infrastructure center  within the National Institute of Chemistry, Slovenia

Contact

  • +386 1 4760 335
  • info@ctgct.si
  • Hajdrihova 19, 1001 Ljubljana

Privacy policy

  • Cookies

Follow us

X Twitter Brands SolidX-twitter

LinkedIn

Bluesky Brands Solid Bluesky

Funding

 

Eu Logo

Ukri Logo

Ifeelslovenia Logo 400

Project: 101059842 – CTGCT – HORIZON-WIDERA-
Co-funded by the European Union, this project has received funding from Horizon Europe (grant agreement No. 101059842) and European Regional Development Fund EU under Slovenia’s Cohesion Policy Programme 2021-2027 (grant agreement No. C3360-25-952005) and the UK Research and Innovation (UKRI) under the UK government’s Horizon Europe funding guarantee (grant number 10069462). Views and opinions expressed are of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency (REA). Neither the European Commission nor the granting authority can be held responsible for them.


CTGCT © 2026
Website production: Kreativna tovarna